Takeda has bought US biotech PvP Biologics for $330 million, adding a potential new form of therapy for coeliac ... and the company already markets Entyvio (vedolizumab), a blockbuster approved ...

An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.

Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing ...

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...

Purpose: The chemical interactions that cause drug incompatibility in solutions, with emphasis on the acid-base and ionized-nonionized forms of organic, weak, electrolyte drugs, are examined.

Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...

Oxide nanoparticles, particularly iron oxide, ceria and silica nanoparticles, hold significant promise for biomedical applications owing to their unique magnetic, catalytic and porous properties ...

It is noteworthy that this drug has U.S. Food and Drug Administration approval for patients with psoriasis.

With repeated use, the circuit adjusts to the drug’s effect, reducing sensitivity and making it hard to receive other forms of pleasurable stimulation. As a result, there are alterations in brain ...

the combined use of which should offer protection options even in the case of highly mutated virus forms. Despite most of the applications for nanobody-based reagents were conceived for few specific ...